Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

Aldeyra enrols first patient in Phase lll trial of reproxalap

T2-weighted MR images of a 25-year-old Sjögren-Larsson syndrome patient. BioMed Central Ltd.

Go Top